Affinity Investment Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $859K | Sell |
7,145
-5,415
| -43% | -$625K | 0.54% | 64 |
|
|
2025
Q4 | $1.32M | Sell |
12,560
-165
| -1% | -$15.5K | 0.88% | 43 |
|
|
2025
Q3 | $1.07M | Sell |
12,725
-3,543
| -22% | -$292K | 0.72% | 48 |
|
|
2025
Q2 | $1.29M | Sell |
16,268
-260
| -2% | -$20.7K | 0.97% | 41 |
|
|
2025
Q1 | $1.48M | Sell |
16,528
-177
| -1% | -$16.5K | 1.21% | 21 |
|
|
2024
Q4 | $1.66M | Sell |
16,705
-6,709
| -29% | -$692K | 1.38% | 16 |
|
|
2024
Q3 | $2.66M | Sell |
23,414
-222
| -0.9% | -$26.4K | 1.82% | 10 |
|
|
2024
Q2 | $2.93M | Buy |
23,636
+3,586
| +18% | +$462K | 2.2% | 6 |
|
|
2024
Q1 | $2.65M | Buy |
20,050
+1,731
| +9% | +$213K | 1.93% | 9 |
|
|
2023
Q4 | $2M | Sell |
18,319
-4,397
| -19% | -$456K | 1.36% | 14 |
|
|
2023
Q3 | $2.34M | Sell |
22,716
-1,772
| -7% | -$191K | 1.51% | 7 |
|
|
2023
Q2 | $2.83M | Sell |
24,488
-6,073
| -20% | -$690K | 1.64% | 4 |
|
|
2023
Q1 | $3.25M | Sell |
30,561
-11,311
| -27% | -$1.22M | 1.74% | 4 |
|
|
2022
Q4 | $4.65M | Sell |
41,872
-3,461
| -8% | -$354K | 2.14% | 4 |
|
|
2022
Q3 | $3.9M | Sell |
45,333
-1,264
| -3% | -$113K | 2.03% | 4 |
|
|
2022
Q2 | $4.25M | Buy |
46,597
+9,815
| +27% | +$870K | 2.07% | 4 |
|
|
2022
Q1 | $3.02M | Sell |
36,782
-809
| -2% | -$63.8K | 1.24% | 16 |
|
|
2021
Q4 | $2.88M | Sell |
37,591
-316
| -0.8% | -$25.2K | 1.16% | 22 |
|
|
2021
Q3 | $2.85M | Buy |
37,907
+4,934
| +15% | +$375K | 1.28% | 18 |
|
|
2021
Q2 | $2.56M | Sell |
32,973
-13,916
| -30% | -$1.04M | 1.16% | 23 |
|
|
2021
Q1 | $3.45M | Buy |
46,889
+164
| +0.4% | +$12.1K | 1.26% | 25 |
|
|
2020
Q4 | $3.65M | Buy |
46,725
+248
| +0.5% | +$19K | 1.47% | 20 |
|
|
2020
Q3 | $3.68M | Buy |
46,477
+1,858
| +4% | +$146K | 1.61% | 18 |
|
|
2020
Q2 | $3.29M | Sell |
44,619
-11,947
| -21% | -$899K | 1.56% | 16 |
|
|
2020
Q1 | $4.15M | Buy |
56,566
+14,176
| +33% | +$1.11M | 2.12% | 12 |
|
|
2019
Q4 | $3.68M | Sell |
42,390
-23,092
| -35% | -$1.9M | 1.33% | 29 |
|
|
2019
Q3 | $5.26M | Buy |
+65,482
| New | +$5.25M | 1.65% | 18 |
|
|
2018
Q1 | – | Sell |
-5,030
| Closed | -$270K | – | 190 |
|
|
2017
Q4 | $270K | Hold |
5,030
| – | – | 0.03% | 145 |
|
|
2017
Q3 | $307K | Hold |
5,030
| – | – | 0.04% | 127 |
|
|
2017
Q2 | $308K | Sell |
5,030
-573
| -10% | -$34.9K | 0.04% | 118 |
|
|
2017
Q1 | $340K | Buy |
+5,603
| New | +$340K | 0.03% | 141 |
|
|
2016
Q3 | – | Sell |
-7,336
| Closed | -$403K | – | 170 |
|
|
2016
Q2 | $403K | Hold |
7,336
| – | – | 0.03% | 123 |
|
|
2016
Q1 | $370K | Hold |
7,336
| – | – | 0.03% | 119 |
|
|
2015
Q4 | $370K | Sell |
7,336
-5,408
| -42% | -$273K | 0.03% | 127 |
|
|
2015
Q3 | $601K | Hold |
12,744
| – | – | 0.05% | 122 |
|
|
2015
Q2 | $692K | Hold |
12,744
| – | – | 0.06% | 111 |
|
|
2015
Q1 | $699K | Buy |
12,744
+5,408
| +74% | +$306K | 0.05% | 105 |
|
|
2014
Q4 | $398K | Hold |
7,336
| – | – | 0.04% | 105 |
|
|
2014
Q3 | $415K | Hold |
7,336
| – | – | 0.04% | 105 |
|
|
2014
Q2 | $405K | Hold |
7,336
| – | – | 0.05% | 73 |
|
|
2014
Q1 | $397K | Hold |
7,336
| – | – | 0.05% | 74 |
|
|
2013
Q4 | $350K | Hold |
7,336
| – | – | 0.04% | 77 |
|
|
2013
Q3 | $333K | Hold |
7,336
| – | – | 0.04% | 76 |
|
|
2013
Q2 | $325K | Buy |
+7,336
| New | +$328K | 0.03% | 105 |
|
Other funds holding MRK
VCM
VPM
Affinity Investment Advisors's MRK Position: Q1 2026 in Review
Affinity Investment Advisors reduced its Merck (MRK) stake by 43% in Q1 2026, selling an estimated $625K and leaving 7,145 shares worth $859K. The position accounts for 0.54% of the portfolio, ranked #64.
Affinity Investment Advisors first reported a position in MRK in Q2 2013 and has held it in 44 quarters since. The position peaked at $5.26M in Q3 2019. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Affinity Investment Advisors held 7,145 shares of Merck worth $859K as of Q1 2026.
- Affinity Investment Advisors sold 5,415 Merck shares in Q1 2026, an estimated $625K.
- Merck made up 0.54% of Affinity Investment Advisors's portfolio in Q1 2026, its #64 holding.
- Affinity Investment Advisors first reported a position in Merck in Q2 2013 and has held it in 44 quarters since.
- Affinity Investment Advisors's Merck position peaked at $5.26M in Q3 2019.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Affinity Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.